World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
47
Citations
9604
World Ranking
6152
National Ranking
3345

Best Publications

  • Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial.

    David Mataix-Cols;Isaac M. Marks;John H. Greist;Kenneth A. Kobak

  • Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

    John h. Greist;James W. Jefferson;Kenneth A. Kobak;David J. Katzelnick

  • Mini-SPIN: A brief screening assessment for generalized social anxiety disorder

    Kathryn M. Connor;Kenneth A. Kobak;L. Erik Churchill;David Katzelnick

  • Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).

    Janet B. W. Williams;Kenneth A. Kobak

  • Randomized trial of a depression management program in high utilizers of medical care.

    David J. Katzelnick;Gregory E. Simon;Steven D. Pearson;Willard G. Manning

  • Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.

    John H Greist;Isaac M Marks;Lee Baer;Kenneth A Kobak

  • Impact of Generalized Social Anxiety Disorder in Managed Care

    David J. Katzelnick;Kenneth A. Kobak;Thomas DeLeire;Henry J. Henk

  • A computer-administered telephone interview to identify mental disorders.

    Kenneth A. Kobak;Leslie V.H. Taylor;Susan L. Dottl;John H. Greist

  • The GRID-HAMD : standardization of the Hamilton Depression Rating Scale

    Janet B.W. Williams;Kenneth A. Kobak;Per Bech;Nina Engelhardt

  • Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis.

    Kenneth A. Kobak;John H. Greist;James W. Jefferson;David J. Katzelnick

  • Sertraline for social phobia: A double-blind, placebo-controlled crossover study.

    David J. Katzelnick;Kenneth A. Kobak;John H. Greist;James W. Jefferson

  • Development of Three Web-Based Computerized Versions of the Kiddie Schedule for Affective Disorders and Schizophrenia Child Psychiatric Diagnostic Interview: Preliminary Validity Data.

    Lisa Townsend;Kenneth Kobak;Catherine Kearney;Michael Milham

  • A 1 Year Double-Blind Placebo-Controlled Fixed Dose Study of Sertraline in the Treatment of Obsessive-Compulsive Disorder

    J. H. Greist;J. W. Jefferson;K. A. Kobak;G. Chouinard

  • Reliability and Validity of the Hamilton Depression Inventory: A Paper-and-Pencil Version of the Hamilton Depression Rating Scale Clinical Interview

    William M. Reynolds;Kenneth A. Kobak

  • Medical Costs Attributed to Depression Among Patients With a History of High Medical Expenses in a Health Maintenance Organization

    Henry J. Henk;David J. Katzelnick;Kenneth A. Kobak;John H. Greist

  • A Computer-Administered Version of the Yale-Brown Obsessive-Compulsive Scale

    Rochelle Rosenfeld;Reuven Dar;Don Anderson;Kenneth A. Kobak

  • Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?

    Kenneth A. Kobak;John M. Kane;Michael E. Thase;Andrew A. Nierenberg

  • Computer-administered clinical rating scales - A review

    Kenneth A. Kobak;John H. Greist;James W. Jefferson;David J. Katzelnick

  • Computerized assessment of depression and anxiety over the telephone using interactive voice response.

    Kenneth A. Kobak;John H. Greist;James W. Jefferson;James C. Mundt

  • Brofaromine for Social Phobia: A Multicenter, Placebo-Controlled, Double-Blind Study

    Michael Lott;John H. Greist;James W. Jefferson;Kenneth A. Kobak

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: